These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-001600-12 Fluval AB Vaccine Serologic Clinical Trial 2004-10-15 due-trials
Reported results 2005-002705-23 FluvalAB Influenza Vaccine Serologic Clinical Trial for 2005-2006 Influenza Season 2005-10-20 due-trials
Reported results 2006-002789-20 FluvalAB Influenza Vaccine Serologic Clinical Trial for 2006-2007 Influenza Season 2006-10-14 due-trials
Reported results 2007-002614-19 FluvalAB Seasonal Influenza Vaccine Serologic Clinical Trial for 2007-2008 Influenza Season 2007-10-06 due-trials
Reported results 2008-003655-74 FluvalAB Seasonal Influenza Vaccine Serologic Clinical Trial for 2008-2009 Influenza Season 2008-09-29 due-trials
Completed, but no date, and reported results 2009-012555-22 Serologic Study of FluvalAB Influenza Vaccine (Trivalent, Seasonal) intended to Use in the 2009-2010 Vaccination Season bad-data
Reported results 2009-014765-74 Tolerability and Safety Study of Fluval P Monovalent Influenza Vaccine in Children 2010-06-03 due-trials
Reported results 2009-014807-30 Tolerability and Immunogenicity Study of Fluval P Monovalent Influenza Vaccine in Children and Adolescents 2010-06-03 due-trials
Reported results 2010-021071-83 Tolerability and Immunogenicity Study of FluvalAB Influenza Vaccine (trivalent, seasonal, active ingredient content: 15 μg HA/strain/0.5 mL) in Adults and Elderly Person 2010-10-26 due-trials
Reported results 2011-002158-30 Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine (trivalent, seasonal, active ingredient content: 15 μg HA/strain/0.5 mL) in Adults and Elderly Persons 2011-08-24 due-trials
Reported results 2011-003166-32 A Randomized, Double-blind, Multi-Center Study to Evaluate Safety and Immunogenicity of One Dose of Four FLUVAL AB-like (Trivalent, Whole Virus, Aluminium Phosphate Gel Adjuvanted) Influenza Vaccines ... 2011-10-17 due-trials
Reported results 2011-003314-16 A Randomized, Active Controlled, Double-blind, Multi-Centre Study to Evaluate Safety and Immunogenicity of One Dose of FLUVAL AB-like (Trivalent, Whole Virus, Aluminium Phosphate Gel Adjuvanted) Influ... 2012-03-21 due-trials
Reported results 2012-002379-32 Tolerability and Immunogenicity Study of FLUVAL AB Influenza Vaccine (trivalent, seasonal, active ingredient content: 15 μgHA/strain/0.5 mL) in Adults and Elderly Persons 2012-09-19 due-trials
Reported results 2013-002153-30 Tolerability and Immunogenicity Study of FLUVAL AB Influenza Vaccine (trivalent, seasonal, active ingredient content: 15 μgHA/strain/0.5 mL) for the Use in the Season 2013/2014 in Adults and Elderly S... 2013-09-17 due-trials
Ongoing, reported early 2013-003449-40 Immunogenicity and Tolerability Study of FLUVAL AB Novo Suspension for Injection (trivalent, seasonal influenza vaccine, active ingredient content: 6 μg HA/strain/0.5 ml) for Children and Adolescents not-yet-due